SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-13-001289
Filing Date
2013-07-01
Accepted
2013-07-01 17:19:14
Documents
1
Period of Report
2013-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3424
  Complete submission text file 0001078782-13-001289.txt   5042
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMPRIMIS PHARMACEUTICALS, INC. 437 S HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address
Abrams Jeffrey J (Reporting) CIK: 0001421168 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 13945611